Pharmesis International Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 18.77 million compared to CNY 25.16 million a year ago. Net loss was CNY 3.05 million compared to CNY 0.299 million a year ago. Basic loss per share from continuing operations was CNY 0.133 compared to CNY 0.013 a year ago.